Editorial: Mouse models to study sepsis syndrome in humans

Journal of Leukocyte Biology

Volumn 86, Issue 2, 2009, Pages 199-201

  Warren, H Shaw ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Cell death; Innate immunity

Indexed keywords

CYTOKINE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; AUTACOID;

ANTIBIOTIC RESISTANCE; APOPTOSIS; BACTERIAL PERITONITIS; BACTERICIDAL ACTIVITY; BONE MARROW CELL; CD34 SELECTION; CELL LINEAGE; CONSENSUS; CYTOKINE RELEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EDITORIAL; ENDOTHELIUM CELL; EX VIVO STUDY; HUMAN; HYPOTENSION; IMMUNOCOMPETENT CELL; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; INTOXICATION; LIVER CELL; LYMPHOID CELL; MICROORGANISM; MONOCYTE; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RODENT; SEPSIS; ANIMAL; BACTERIAL INFECTION; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; METHODOLOGY; MICROBIOLOGY; NOTE; PERITONITIS; STEM CELL TRANSPLANTATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; APOPTOSIS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOPOIESIS; MICE; MULTIPLE ORGAN FAILURE; PERITONITIS; STEM CELL TRANSPLANTATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 69449107598     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0309210     Document Type: Editorial

References (18)

1. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M. R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310. (Pubitemid 32641789)
2. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., Sibbald, W. J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101, 1644-1655.
3. Hubbard, W. J., Choudhry, M., Schwacha, M. G., Kerby, J. D., Rue, L. W. III, Bland, K. I., Chaudry, I. H. (2005) Cecal ligation and puncture. Shock 24, Suppl. 1:52-57.
4. Glode, L. M., Mergenhagen, S. E., Rosenstreich, D. L. (1976) Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo. Infect. Immun. 14, 626-630.
5. McCuskey, R. S., McCuskey, P. A., Urbaschek, R., Urbaschek, B. (1984) Species differences in Kupffer cells and endotoxin sensitivity. Infect. Immun. 45, 278-280. (Pubitemid 14078953)
6. Schaedler, R., Dubos, R. J. (1961) The susceptibility of mice to bacterial endotoxins. J. Exp. Med. 113, 559-570.
7. Reynolds, K., Novosad, B., Hoffhines, A., Gipson, J., Johnson, J., Peters, J., Gonzalez, F., Gimble, J., Hill, M. (2002) Pretreatment with troglitazone decreases lethality during endotoxemia in mice. J. Endotoxin Res. 8, 307-314. (Pubitemid 35049480)
8. Taveira da Silva, A. M., Kaulbach, H. C., Chuidian, F. S., Lambert, D. R., Suffredini, A. F., Danner, R. L. (1993) Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N. Engl. J. Med. 328, 1457-1460.
9. Sauter, C., Wolfensberger, C. (1980) Interferon in human serum after injection of endotoxin. Lancet 2, 852-853. (Pubitemid 10006693)
10. Lowry, S. F. (2005) Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24, Suppl. 1:94-100.
11. Mestas, J., Hughes, C. C. (2004) Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738. (Pubitemid 38263654)
12. Shultz, L. D., Ishikawa, F., Greiner, D. L. (2007) Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7, 118-130. (Pubitemid 46174859)
13. Macchiarini, F., Manz, M. G., Palucka, A. K., Shultz, L. D. (2005) Humanized mice: are we there yet? J. Exp. Med. 202, 1307-1311. (Pubitemid 41668732)
14. Ayala, A., Herdon, C. D., Lehman, D. L., Ayala, C. A., Chaudry, I. H. (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87, 4261-4275. (Pubitemid 26152269)
15. Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., Karl, I. E. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27, 1230-1251. (Pubitemid 29379358)
16. Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., Karl, I. E. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96, 14541-14546.
17. Warren, H. S., Amato, S. F., Fitting, C., Black, K. M., Loiselle, P. M., Pasternack, M. S., Cavaillon, J.-M. (1993) Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J. Exp. Med. 177, 89-97. (Pubitemid 23008088)
18. Cavaillon, J.-M., Fitting, C., Haeffner-Cavaillon, N., Kirsch, S. J., Warren, H. S. (1990) Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect. Immun. 58, 2375-2382. (Pubitemid 20212321)